Semnur Pharmaceuticals

SMNR · OTC

$0.40−$0.027 (−6.32%)TodayMarket closed ·
Prev close $0.427

Who owns SMNR

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 84.3% of SMNR’s shares.

  • Scilex Holding Co78.8%
  • Biconomy PTE, LTD5.4%
  • T. Rowe Price Associates, Inc.0.0%
  • Vanguard Global Advisers LLC0.0%
  • Next 6 largest institutions0.0%
  • All other shareholders15.7%
Top institutional holders of SMNR
HolderShares% of shares
Scilex Holding Co181.52M78.85%
Biconomy PTE, LTD12.50M5.43%
T. Rowe Price Associates, Inc.6.90K0.00%
Vanguard Global Advisers LLC1.53K0.00%
BlackRock Investment Management, LLC1.26K0.00%
Metropolitan Life Insurance Co. (US)6270.00%
KLP Kapitalforvaltning AS2900.00%
MRB Fund Partners AG2210.00%
WEALTHGATE GmbH1770.00%
GAMMA Investing LLC1160.00%

Largest mutual fund holders

Top mutual fund holders of SMNR
HolderShares% of shares
T. Rowe Price Extended Equity Market Index Fund6.90K0.00%
Vanguard US Equity Index Fund1.53K0.00%
MetLife Russell 2000 Index Portfolio6270.00%
KLP AksjeGlobal Small Cap Indeks2900.00%
BELFUND SICAV-Belinvest Equity Fund2210.00%

Insider trades

Form 4 filings by officers, directors and large holders

Insiders made no open-market buys or sales of SMNR in the last 6 months.

Latest SMNR insider transactions
InsiderTypeSharesValue
Scilex Holding CoOther7.03M—

Short interest

Settled Sep 30, 2026

Shares short
88.64K
Days to cover
10.63
% of shares outstanding
0.04%
Average daily volume
8.34K
Change since last report
−3.6%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.